Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing and distribution of pharmaceutical products in domestic and international markets through a third-party distribution network. The company offers a portfolio of 832 products as of May 31, 2022, including antibiotics, antifungals, antimalarials, antidiabetics, dental care products, proton pump inhibitors, antihistamines, antihypertensives, antiparasitics, multivitamins, multiminerals, and NSAIDs. Its core business includes ethical marketing of pharmaceutical formulations internationally under its brand and sourcing approved formulations through contract manufacturers for both domestic and global markets. Trident Lifeline has a presence in India as well as in African, Latin American, and East Asian countries, with registered or under-registration products in Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.